Angle PLC Announces Notice of Results
-
Lucu's Bordeaux-Begles eye 'neutralising' Pollock in Champions Cup final
-
Departing Ancelotti wishes Alonso luck as his Real Madrid successor
-
Chelsea can cope with pressure of top-five battle, says Maresca
-
Brook's quickfire fifty takes England to 565-6 dec against Zimbabwe
-
Alexander-Arnold 'deserves' his part in Liverpool title party: Slot
-
Missing out on Champions League would be huge blow: Newcastle boss Howe
-
Fire walkers defy pain in ancient Greek ritual
-
Stocks firm, dollar drops at end of rocky week
-
Dismayed Chinese students ponder prospects after Trump Harvard ban
-
Slot unsure if Alexander-Arnold will play in Liverpool season finale
-
Helmsman of cargo ship run aground in Norway was likely asleep: reports
-
Sri Lanka's ex-skipper Mathews to quit Test cricket
-
Ban on ousted ex-ruling party divides Bangladesh voters
-
UK newspaper The Telegraph set for US ownership
-
President vows oil won't threaten Suriname's carbon negative status
-
Saudi-based Toney recalled to England squad by Tuchel
-
Son's European 'milestone' shows South Korea strength - FA
-
Stocks bounce after Treasury-led sell-off
-
German growth upgraded on pre-tariff export surge
-
Flood victims confront damage after record deluge in eastern Australia
-
Stocks mixed after Treasury-led sell-off
-
Iran, US to hold new round of nuclear talks in Rome
-
Fears for crops as drought hits northern Europe
-
UFC champ Zhang says acting 'experiment' and fighting not so different
-
British king to visit Ottawa amid Trump-Canada tension
-
Cannes maitre d'hotel retires with memories of stars
-
Franco symbols mark Spanish streets 50 years after dictator's death
-
Blaze-hit Athens suburb trains to tackle new fire season
-
Thai athlete, 105, unrivalled but not lonely at World Masters Games
-
Japan core inflation tops forecasts as rice prices almost double
-
Row erupts as German city plans safe room for crack addicts
-
Swimming champ McEvoy says Enhanced Games 'record' means nothing
-
Japan PM presses Trump on tariffs ahead of new talks
-
Gilgeous-Alexander leads Thunder to 2-0 lead over Minnesota
-
US tariff tensions test Southeast Asian leaders at regional summit
-
Trump attends memecoin gala as protesters slam 'crypto corruption'
-
The pioneering Vietnamese professor taught by French maths genius
-
Asian stocks bounce back after Treasury-led sell-off
-
Israeli director Nadav Lapid decries 'blindness' over Gaza
-
In tune with nature: expert sounds out all of Ireland's bird species
-
Verdict due in Kardashian Paris robbery trial
-
Russo leads Arsenal quest to slay Barcelona beast in Champions League final
-
Premier League dream turns sour for promoted clubs
-
New boys Bordeaux-Begles face Northampton for Champions Cup glory
-
Rare earth production outside China 'major milestone'
-
Did George Floyd protesters miss their moment for change?
-
Do grabs share of lead at LPGA Mexico event
-
Pak grabs lead as Scheffler looks for third straight win
-
Owe the IRS? Clear Start Tax Shares Critical Do's and Don'ts to Avoid Costly Mistakes
-
Interactive Strength Inc. (Nasdaq:TRNR) Shares New CEO Q&A Update Featuring TRNR and Wattbike CEO's
NYSE - LSE
Angle PLC Announces Notice of Results
Notice of Preliminary Results and Webcast
GUILDFORD, SURREY / ACCESS Newswire / May 23, 2025 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) diagnostic solutions for use in research, drug development and clinical oncology, will be releasing its preliminary results for the year ended 31 December 2024 on Wednesday 28 May 2025.
A meeting for analysts will be held at 11:00 am BST on Wednesday 28 May 2025 at the offices of FTI Consulting, 200 Aldersgate, Aldersgate Street, London, EC1A 4HD.
A live webcast of the analyst meeting can be accessed via ANGLE's Investor Centre page, https://angleplc.com/investor-relations/corporate-presentations/, with Q&A participation reserved for analysts only. Please register in advance and log on to the webcast approximately 5 minutes before 11:00 am on the day of the results. A recording of the webcast will be made available on ANGLE's website following the results meeting.
For further information:
ANGLE plc | +44 (0) 1483 343434 |
Andrew Newland, Chief Executive | |
Berenberg (NOMAD and Corporate Broker) | +44 (0) 20 3207 7800 |
FTI Consulting | +44 (0) 203 727 1000 +1 (212) 850 5624 |
For Frequently Used Terms, please see the Company's website on https://angleplc.com/investor-relations/glossary/
Notes for editors
About ANGLE plc
ANGLE is a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology using a simple blood sample. ANGLE's FDA cleared and patent protected CTC harvesting technology known as the Parsortix® PC1 System enables complete downstream analysis of the sample including whole cell imaging and proteomic analysis and full genomic and transcriptomic molecular analysis.
ANGLE's commercial businesses are focusing on clinical services and diagnostic products. The clinical services business is offered through ANGLE's GCLP-compliant laboratories. Services include custom made assay development and clinical trial testing for pharma. Products include the Parsortix system, associated consumables and assays.
Over 100 peer-reviewed publications have demonstrated the performance of the Parsortix system. For more information, visit www.angleplc.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
SOURCE: ANGLE plc
View the original press release on ACCESS Newswire
Y.Nakamura--AMWN